A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer
- 1 September 1997
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 45 (3) , 251-262
- https://doi.org/10.1023/a:1005891506092
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Meeting Highlights: International Consensus Panel on the Treatment of Primary Breast CancerJNCI Journal of the National Cancer Institute, 1995
- Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary MalignanciesJNCI Journal of the National Cancer Institute, 1995
- Apoptosis in Toremifene-Induced Growth Inhibition of Human Breast Cancer Cells In Vivo and In VitroJNCI Journal of the National Cancer Institute, 1993
- Agonistic and Antagonistic Effects of Antiestrogens in Different Target OrgansActa Oncologica, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Prospects for Antiestrogen Chemoprevention of Breast CancerJNCI Journal of the National Cancer Institute, 1990
- A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancerBritish Journal of Cancer, 1989
- A new triphenylethylene compound, Fc-1157aCancer Chemotherapy and Pharmacology, 1986
- A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bdBritish Journal of Cancer, 1984
- Nonsteroidal antiestrogens: Their biological effects and potential mechanisms of actionJournal of Toxicology and Environmental Health, 1978